The pathobiology of the osteoclast.
暂无分享,去创建一个
[1] A. F. Stewart,et al. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. , 1980, The New England journal of medicine.
[2] T. Powles,et al. BREAST-CANCER OSTEOLYSIS, BONE METASTASES, AND ANTI-OSTEOLYTIC EFFECT OF ASPIRIN , 1976, The Lancet.
[3] J. Puzas,et al. Parathyroid hormone stimulation of collagenase secretion by isolated bone cells. , 1979, Endocrinology.
[4] E Bell,et al. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[5] P. Meunier,et al. Quantitative histology of myeloma‐induced bone changes , 1982, British journal of haematology.
[6] G. Mundy,et al. Direct resorption of bone by human breast cancer cells in vitro , 1978, Nature.
[7] A. Tashjian,et al. Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcoma. , 1973, Prostaglandins.
[8] T. Martin,et al. Activation of adenosine 3',5'-monophosphate-dependent protein kinase in normal and malignant bone cells by parathyroid hormone, prostaglandin E2, and prostacyclin. , 1981, Endocrinology.
[9] D. Klein,et al. Prostaglandins: stimulation of bone resorption in tissue culture. , 1970, Endocrinology.
[10] H. Heath,et al. Calcitonin: physiology and pathophysiology. , 1981, The New England journal of medicine.
[11] Z. Jaworski,et al. Kinetics of osteoclasts and their nuclei in evolving secondary Haversian systems. , 1981, Journal of anatomy.
[12] J. Oates,et al. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. , 1975, The New England journal of medicine.
[13] G. W. Bernard,et al. Osteoclast formation in vitro from bone marrow mononuclear cells in osteoclast-free bone. , 1981, The American journal of anatomy.
[14] J. Bergeron,et al. Direct in vivo demonstration by radioautography of specific binding sites for calcitonin in skeletal and renal tissues of the rat , 1980, The Journal of cell biology.
[15] V. Raina. Normal osteoid tissue , 1972, Journal of clinical pathology.
[16] S. Marks,et al. CHAPTER 6 – Mammalian Osteopetrosis—A Model for Studying Cellular and Humoral Factors in Bone Resorption , 1976 .
[17] M. Wills,et al. Prostaglandins, bone resorption and hypercalcemia. , 1973, The New England journal of medicine.
[18] C. Andrew L. Bassett,et al. Generation of Electric Potentials by Bone in Response to Mechanical Stress , 1962, Science.
[19] C. Galasko. Mechanisms of bone destruction in the development of skeletal metastases , 1976, Nature.
[20] W. Sturtridge,et al. Immunohistochemical demonstration of calcitonin binding to specific cell types in fixed rat bone tissue. , 1981, Endocrinology.
[21] N. Athanasou,et al. Effect of parathyroid hormone and calcitonin on the cytoplasmic spreading of isolated osteoclasts. , 1984, The Journal of endocrinology.
[22] J. Reynolds,et al. Mouse osteoblasts synthesize collagenase in response to bone resorbing agents. , 1984, Biochimica et biophysica acta.
[23] S. Rushton,et al. The effect of prostaglandin synthesis inhibitors and diphosphonates on tumour‐mediated osteolysis , 1980, The British journal of surgery.
[24] J. Harrelson,et al. Newer knowledge of vitamin D and its metabolites in health and disease. , 1979, Clinical orthopaedics and related research.
[25] J. Reynolds,et al. A factor synthesized by rabbit periosteal fibroblasts stimulates bone resorption and collagenase production by connective tissue cells in vitro. , 1984, Biochimica et biophysica acta.
[26] S. Marx,et al. Calcitonin Receptors of Kidney and Bone , 1972, Science.
[27] R. Baron,et al. Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity. , 1982, The Journal of clinical endocrinology and metabolism.
[28] S. Teitelbaum,et al. Multinucleation enhances macrophage-mediated bone resorption. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[29] S. Marks,et al. The origin of osteoclasts: evidence, clinical implications and investigative challenges of an extra-skeletal source. , 1983, Journal of oral pathology.
[30] S. Mergenhagen,et al. Macrophage-lymphocyte synergy in the production of osteoclast activating factor. , 1974, Journal of immunology.
[31] I Binderman,et al. Bone remodelling induced by physical stress is prostaglandin E2 mediated. , 1980, Biochimica et biophysica acta.
[32] F. Singer,et al. Urinary and nephrogenous adenosine 3',5'-monophosphate in the hypercalcemia of malignancy. , 1981, The Journal of clinical endocrinology and metabolism.
[33] B. Thomson,et al. The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. , 1985, Endocrinology.
[34] S. Miller,et al. Morphological and ultrastructural aspects of the activation of avian medullary bone osteoclasts by parathyroid hormone , 1984, The Anatomical record.
[35] H. DeLuca,et al. 1,25-Dihydroxycholecalciferol: A Potent Stimulator of Bone Resorption in Tissue Culture , 1972, Science.
[36] G. Mundy,et al. Evidence for the secretion of an osteoclast stimulating factor in myeloma. , 1974, The New England journal of medicine.
[37] G. Mundy,et al. Association of increased cyclic adenosine 3':5'-monophosphate content in cultured human breast cancer cells and release of hydrolytic enzymes and bone-resorbing activity. , 1983, Cancer research.
[38] R. Jilka,et al. Homologous and Heterologous Control of Bone Cell Adenosine 3′,5′-Monophosphate Response to Hormones by Parathormone, Prostaglandin E2, Calcitonin, and 1,25-hydroxycholecalciferol* , 1980 .
[39] B. Thomson,et al. Effect of substrate composition on bone resorption by rabbit osteoclasts. , 1984, Journal of cell science.
[40] L. Avioli,et al. The vitamin D family revisited. , 1984, The New England journal of medicine.
[41] F. Murad,et al. Effect of thyrocalcitonin on adenosine 3':5'-cyclic phosphate formation by rat kidney and bone. , 1970, Proceedings of the National Academy of Sciences of the United States of America.
[42] T. Chambers,et al. Inhibition of osteoclastic motility by prostaglandins I2, E1, E2 and 6‐oxo‐E1 , 1983, The Journal of pathology.
[43] C. Galasko,et al. Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins , 1976, Nature.
[44] J. P. Scherft. The lamina limitans of the organic matrix of calcified cartilage and bone. , 1972, Journal of ultrastructure research.
[45] L. Raisz. Stimulation of Bone Resorption by Parathyroid Hormone in Tissue Culture , 1963, Nature.
[46] A. C. Allison,et al. Membrane fusion reaction: a theory. , 1971, Journal of theoretical biology.
[47] T. Martin,et al. Activity ratio measurements reflect intracellular activation of adenosine 3',5'-monophosphate-dependent protein kinase in osteoblasts. , 1982, Endocrinology.
[48] J. Loutit,et al. RESORPTION OF BONE , 1979, The Lancet.
[49] M. Kaye. When is it an osteoclast? , 1984, Journal of clinical pathology.
[50] Riley Lh,et al. Skeletal changes during prolonged external irradiation: alterations in marrow, growth plate and osteoclast populations. , 1979 .
[51] A. Jones,et al. Parathyroid hormone receptor in intact embryonic chicken bone: characterization and cellular localization , 1982, The Journal of cell biology.
[52] A. Tashjian. Role of prostaglandins in the production of hypercalcemia by tumors. , 1978, Cancer research.
[53] S. Miller,et al. Bone cells in culture: morphologic transformation by hormones. , 1976, Science.
[54] T. Powles,et al. Failure of indomethacin to reduce hydroxyproline excretion or hypercalcemia in patients with breast cancer , 1976 .
[55] T. Chambers,et al. The sensitivity of isolated osteoclasts to morphological transformation by calcitonin. , 1983, The Journal of clinical endocrinology and metabolism.
[56] P. Reitsma,et al. Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[57] D. Alkon,et al. Calcium and cAMP as Synarchic Messengers , 1983 .
[58] R. Baron,et al. Behavior of osteoclasts during a rapid change in their number induced by high doses of parathyroid hormone or calcitonin in intact rats , 1981 .
[59] D. Hume,et al. The mononuclear phagocyte system of the mouse defined by immunohistochemical localisation of antigen F4/80 , 1985 .
[60] E. Bonucci. New knowledge on the origin, function and fate of osteoclasts. , 1981, Clinical orthopaedics and related research.
[61] C. Galasko. The pathological basis for skeletal scintigraphy. , 1972, The Journal of bone and joint surgery. British volume.
[62] R. Jilka,et al. A collagenolytic response to parathormone, 1,25-dihydroxycholecalciferol D3, and prostaglandin E2 in bone of osteopetrotic (mi/mi) mice. , 1983, Endocrinology.
[63] T. Chambers,et al. Phagocytosis and trypsin‐resistant glass adhesion by osteoclasts in culture , 1979, The Journal of pathology.
[64] V. Perry,et al. The mononuclear phagocyte system of the mouse defined by immunohistochemical localisation of antigen F4/80: macrophages associated with epithelia. , 1984, The Anatomical record.
[65] J. Loutit,et al. Longevity of osteoclasts in radiation chimaeras of osteopetrotic beige and normal mice. , 1982, British journal of experimental pathology.
[66] S. Marks,et al. Transformations of osteoclast phenotype in ia rats cured of congenital osteopetrosis , 1982, Journal of morphology.
[67] N. Finlayson,et al. The Growth of Brown-Pearce Carcinoma in the Medullary Cavity of the Rabbit Femur , 1963, British Journal of Cancer.
[68] S. Tsao,et al. Some mechanisms of local bone destruction by squamous carcinomas of the head and neck. , 1981, British Journal of Cancer.
[69] T. Chambers,et al. Calcitonin alters behaviour of isolated osteoclasts , 1982, The Journal of pathology.
[70] E H Burger,et al. In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes , 1982, The Journal of experimental medicine.
[71] G. Mundy,et al. Observations on the mechanism of bone resorption induced by multiple myeloma marrow culture fluids and partially purified osteoclast-activating factor. , 1981, The Journal of clinical investigation.
[72] D. Gingell. Computed surface potential changes with membrane interaction. , 1968, Journal of theoretical biology.
[73] P. Gaillard. Parathyroid gland and bone in vitro. , 1957, Schweizerische medizinische Wochenschrift.
[74] S. Ralston,et al. HYPERCALCAEMIA AND METASTATIC BONE DISEASE: IS THERE A CAUSAL LINK? , 1982, The Lancet.
[75] M. Wills,et al. Prostaglandin Production and Bone Resorption by Dental Cysts , 1973, Nature.
[76] F. Singer,et al. ACUTE EFFECTS OF CALCITONIN ON OSTEOCLASTS IN MAN , 1976, Clinical endocrinology.
[77] A. Badger,et al. Isolation of a bone-resorptive factor from human cancer ascites fluid. , 1978, Cancer research.
[78] W. E. Roberts. Cell population dynamics of periodontal ligament stimulated with parathyroid extract. , 1975, The American journal of anatomy.
[79] E. A. Tonna. Periosteal Osteoclasts, Skeletal Development and Ageing , 1960, Nature.
[80] W. R. Adey,et al. Effects of electromagnetic stimuli on bone and bone cells in vitro: inhibition of responses to parathyroid hormone by low-energy low-frequency fields. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[81] R. Russell,et al. An interleukin 1 like factor stimulates bone resorption in vitro , 1983, Nature.
[82] S. Rodan,et al. Bone resorptive factor produced by osteosarcoma cells with osteoblastic features is PGE2. , 1981, Biochemical and biophysical research communications.
[83] G. Striker,et al. Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man , 1982, Nature.
[84] M. Horton,et al. Cell surface characterization of the human osteoclast: Phenotypic relationship to other bone marrow‐derived cell types , 1984, The Journal of pathology.
[85] S. Sakamoto,et al. Biochemical and immunohistochemical studies on collagenase in resorbing bone in tissue culture. A novel hypothesis for the mechanism of bone resorption. , 1982, Journal of periodontal research.
[86] I. Brazell,et al. The effect of parathyroid extract on cellular activity and plasma calcium levels in vivo. , 1969, The Journal of endocrinology.
[87] S. Miller. Rapid activation of the medullary bone osteoclast cell surface by parathyroid hormone , 1978, The Journal of cell biology.
[88] J. Hock,et al. DNA synthesis is not necessary for osteoclastic responses to parathyroid hormone in cultured fetal rat long bones. , 1983, The Journal of clinical investigation.
[89] S. Krane. Heberden Oration 1980: aspects of the cell biology of the rheumatoid synovial lesion. , 1981, Annals of the rheumatic diseases.
[90] R. Baron,et al. Cellular kinetics of the bone remodeling sequence in the rat , 1982, The Anatomical record.
[91] J. Loutit,et al. The origin of osteoclasts. , 1982, Immunobiology.
[92] H. Hanaoka,et al. The origin of the osteoclast. , 1979, Clinical orthopaedics and related research.
[93] D. Brenner,et al. A study of prostaglandin E2, parathormone, and response to indomethacin in patients with hypercalcemia of malignancy , 1982, Cancer.
[94] T. Chambers. The cellular basis of bone resorption. , 1980, Clinical orthopaedics and related research.
[95] W. Ryan,et al. Effects of prostaglandins and other drugs on the cyclic AMP content of cultured bone cells. , 1976, Prostaglandins.
[96] R. Luben,et al. 1,25-dihydroxycholecalciferol and parathormone: effects on isolated osteoclast-like and osteoblast-like cells. , 1977, Science.
[97] G. Rodan,et al. Cyclic AMP and cyclic GMP: mediators of the mechanical effects on bone remodeling. , 1975, Science.
[98] G. Vaes. Cartilage and bone tissue damage in arthritis: cellular co-operation and enzymatic mechanisms. , 1981, Scandinavian journal of rheumatology. Supplement.
[99] P. Revell,et al. Resorption of bone by isolated rabbit osteoclasts. , 1984, Journal of cell science.
[100] P. Gaillard. Parathyroid gland and bone in vitro. VI , 1959 .
[101] F. Dewhirst,et al. Prostaglandin E2 levels and human periodontal disease. , 1974, Prostaglandins.
[102] Chambers Tj. The cellular basis of bone resorption. , 1980 .
[103] J. I. Rader,et al. Acute reduction in osteoclast number during bone repletion. , 1982, Metabolic bone disease & related research.
[104] T. Martin,et al. Stimulation of plasminogen activator in osteoblast-like cells by bone-resorbing hormones. , 1984, Biochemical and biophysical research communications.
[105] D. Robinson,et al. Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis. , 1975, The Journal of clinical investigation.
[106] Albert K. Harris,et al. Fibroblast traction as a mechanism for collagen morphogenesis , 1981, Nature.
[107] E. Jaffe,et al. Hypercalcemia associated with T-cell lymphoma-leukemia. , 1981, American journal of clinical pathology.
[108] H. DeLuca,et al. Vitamin D is not directly necessary for bone growth and mineralization. , 1984, The American journal of physiology.
[109] P. McSheehy,et al. The effects of calcium regulating hormones on bone resorption by isolated human osteoclastoma cells , 1985, The Journal of pathology.
[110] H P Koeffler,et al. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. , 1983, Blood.
[111] J. Carter,et al. Quantitative bone histology in the hypercalcemia of malignant disease. , 1982, The Journal of clinical endocrinology and metabolism.